Brii Biosciences (02137) Releases Monthly Return for November 2025

Bulletin Express12-03

Brii Biosciences Limited (02137) reported that its authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.000005, totaling USD 6,000. The number of issued shares (excluding treasury shares) rose from 720,936,585 to 721,126,710 during November 2025, while treasury shares stayed at 12,723,500, leading to a total of 733,850,210 shares by month-end.

In terms of share options, 114,500 shares were issued from the 2023 Share Option Scheme, contributing to total funds raised of HKD 121,599. The company also issued 75,625 shares under its Post-IPO Share Award Scheme and 2023 Share Award Scheme. Across these transactions, overall issued shares (excluding treasury shares) increased by 190,125 in November 2025. Treasury shares showed no change for the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113764770?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 16:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113764770","market":"us","top_or_hot":-1,"title":"Brii Biosciences (02137) Releases Monthly Return for November 2025","media":"Bulletin Express","content":"<p>Brii Biosciences Limited (02137) reported that its authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.000005, totaling USD 6,000. The number of issued shares (excluding treasury shares) rose from 720,936,585 to 721,126,710 during November 2025, while treasury shares stayed at 12,723,500, leading to a total of 733,850,210 shares by month-end.</p>\n<p>In terms of share options, 114,500 shares were issued from the 2023 Share Option Scheme, contributing to total funds raised of HKD 121,599. The company also issued 75,625 shares under its Post-IPO Share Award Scheme and 2023 Share Award Scheme. Across these transactions, overall issued shares (excluding treasury shares) increased by 190,125 in November 2025. Treasury shares showed no change for the period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brii Biosciences (02137) Releases Monthly Return for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrii Biosciences (02137) Releases Monthly Return for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 16:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Brii Biosciences Limited (02137) reported that its authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.000005, totaling USD 6,000. The number of issued shares (excluding treasury shares) rose from 720,936,585 to 721,126,710 during November 2025, while treasury shares stayed at 12,723,500, leading to a total of 733,850,210 shares by month-end.</p>\n<p>In terms of share options, 114,500 shares were issued from the 2023 Share Option Scheme, contributing to total funds raised of HKD 121,599. The company also issued 75,625 shares under its Post-IPO Share Award Scheme and 2023 Share Award Scheme. Across these transactions, overall issued shares (excluding treasury shares) increased by 190,125 in November 2025. Treasury shares showed no change for the period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02137","symbol_name":"腾盛博药-B","start_time":0,"source_url":"","article_id":"1113764770","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113764770","pubTimestamp":1764752185,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Brii Biosciences Limited (02137) reported that its authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.000005, totaling USD 6,000. The number of issued shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02137":"腾盛博药-B"},"translate_title":"布瑞生物(02137)发布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02137":1},"content_text":"Brii Biosciences Limited (02137) reported that its authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.000005, totaling USD 6,000. The number of issued shares (excluding treasury shares) rose from 720,936,585 to 721,126,710 during November 2025, while treasury shares stayed at 12,723,500, leading to a total of 733,850,210 shares by month-end.\nIn terms of share options, 114,500 shares were issued from the 2023 Share Option Scheme, contributing to total funds raised of HKD 121,599. The company also issued 75,625 shares under its Post-IPO Share Award Scheme and 2023 Share Award Scheme. Across these transactions, overall issued shares (excluding treasury shares) increased by 190,125 in November 2025. Treasury shares showed no change for the period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113764770","isCrawlerRequest":true}